A Prognostic Model Based on Residual Cancer Burden and Tumor-Infiltrating Lymphocytes on Residual Disease after Neoadjuvant Therapy in HER2+ Breast Cancer

PURPOSE: We aim to evaluate the prognostic significance of tumor-infiltrating lymphocyte on residual disease (RD-TIL) in HER2+ patients with breast cancer who failed to achieve pathologic complete response (pCR) after anti-HER2+ chemotherapy (CT)-based neoadjuvant treatment (NAT). We assessed the fe...

Descripción completa

Detalles Bibliográficos
Autores principales: Miglietta, Federica, Ragazzi, Moira, Fernandes, Bethania, Griguolo, Gaia, Massa, Davide, Girardi, Fabio, Bottosso, Michele, Bisagni, Alessandra, Zarrilli, Giovanni, Porra, Francesca, Iannaccone, Daniela, Dore, Leocadia, Gaudio, Mariangela, Santandrea, Giacomo, Fassan, Matteo, Lo Mele, Marcello, De Sanctis, Rita, Zambelli, Alberto, Bisagni, Giancarlo, Guarneri, Valentina, Dieci, Maria Vittoria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2023
Materias:
Translational Cancer Mechanisms and Therapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472099/
https://www.ncbi.nlm.nih.gov/pubmed/37417941
http://dx.doi.org/10.1158/1078-0432.CCR-23-0480

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472099/
https://www.ncbi.nlm.nih.gov/pubmed/37417941
http://dx.doi.org/10.1158/1078-0432.CCR-23-0480

Ejemplares similares